| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
55,220,000 |
| Market
Cap: |
6.63(M) |
| Last
Volume: |
36,921,266 |
Avg
Vol: |
36,819,648 |
| 52
Week Range: |
$0.03 - $2.83 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Retail |
| Level
III Sector: |
Drug Stores |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Rite Aid provides an array of whole being health products and services. Co. reports its business in two segments: Retail Pharmacy Segment, which provides a range of healthcare services, including administering immunizations against coronavirus, the flu, shingles and more, as well as Health Dialog, a provider of healthcare coaching and disease management services to health plans and employers; and Pharmacy Services Segment, which includes its pharmacy benefit management (PBM), Elixir, that provides a suite of PBM offerings including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication and pharmacy discount programs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Panzer Mark C |
Sr.EVP,Chief Marketing Officer |
• – – |
2007-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
25,962 |
263,272 |
|
- |
|
| Sari Robert |
EVP & General Counsel |
• – – |
2007-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
14,563 |
76,088 |
|
- |
|
| Panzer Mark C |
Sr.EVP,Chief Marketing Officer |
• – – |
2007-06-24 |
4 |
D |
$6.09 |
$8,812 |
D/D |
(1,447) |
237,310 |
|
- |
|
| Panzer Mark C |
Sr.EVP,Chief Marketing Officer |
• – – |
2007-06-23 |
4 |
D |
$6.09 |
$8,666 |
D/D |
(1,423) |
238,757 |
|
- |
|
| Panzer Mark C |
Sr.EVP,Chief Marketing Officer |
• – – |
2007-06-20 |
4 |
D |
$6.11 |
$8,249 |
D/D |
(1,350) |
240,180 |
|
- |
|
| Sari Robert |
EVP & General Counsel |
• – – |
2007-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
19,112 |
61,525 |
|
- |
|
| De Bruin Jerry Mark |
Executive VP - Pharmacy |
• – – |
2007-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
18,455 |
117,672 |
|
- |
|
| Donley Douglas E |
Senior VP - CAO |
• – – |
2007-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
12,184 |
38,386 |
|
- |
|
| Twomey Kevin |
Executive VP & CFO |
• – – |
2007-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
20,915 |
99,689 |
|
- |
|
| Sammons Mary F |
Chairman,President & CEO |
• • – |
2007-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
153,139 |
1,156,743 |
|
- |
|
| Panzer Mark C |
Sr.EVP,Chief Marketing Officer |
• – – |
2007-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
48,266 |
241,530 |
|
- |
|
| Miller Robert Gerald |
Director |
– • – |
2007-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
26,799 |
39,578 |
|
- |
|
| Mastrian James P |
Sr.EVP & COO |
• – – |
2007-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
68,539 |
406,891 |
|
- |
|
| Legault Pierre |
Senior EVP - CAO |
• – – |
2007-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
|
- |
|
| Jean Coutu Group (pjc) Inc. |
10% Owner |
– – • |
2007-06-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
250,000,000 |
|
- |
|
| De Bruin Jerry Mark |
EVP - Pharmacy |
• – – |
2007-06-04 |
4 |
D |
$6.55 |
$337,410 |
D/D |
(51,513) |
172,704 |
|
- |
|
| Sari Robert |
EVP, General Counsel |
• – – |
2007-06-04 |
4 |
D |
$6.55 |
$71,513 |
D/D |
(10,918) |
42,413 |
|
- |
|
| Mastrian James P |
Senior EVP, COO |
• – – |
2007-06-04 |
4 |
D |
$6.55 |
$1,062,102 |
D/D |
(162,153) |
338,352 |
|
- |
|
| De Bruin Jerry Mark |
Executive VP, Pharmacy |
• – – |
2007-06-04 |
4 |
D |
$6.55 |
$296,807 |
D/D |
(45,314) |
99,217 |
|
- |
|
| De Bruin Jerry Mark |
Executive VP - Pharmacy |
• – – |
2007-04-07 |
4 |
D |
$6.00 |
$2,256 |
D/D |
(376) |
144,531 |
|
- |
|
| Sari Robert |
Executive VP, General Counsel |
• – – |
2007-04-07 |
4 |
D |
$6.00 |
$2,256 |
D/D |
(376) |
53,331 |
|
- |
|
| Donley Douglas E |
Senior VP - Chief Accounting |
• – – |
2007-04-07 |
4 |
D |
$6.00 |
$1,452 |
D/D |
(242) |
26,202 |
|
- |
|
| Sari Robert |
Executive VP - General Counsel |
• – – |
2007-04-05 |
4 |
D |
$6.00 |
$17,514 |
D/D |
(2,919) |
53,707 |
|
- |
|
| Panzer Mark C |
Senior Executive VP |
• – – |
2007-04-05 |
4 |
D |
$6.00 |
$45,804 |
D/D |
(7,634) |
193,264 |
|
- |
|
| Donley Douglas E |
Senior VP - Chief Accounting |
• – – |
2007-04-05 |
4 |
D |
$6.00 |
$11,622 |
D/D |
(1,937) |
26,444 |
|
- |
|
818 Records found
|
|
Page 30 of 33 |
|
|
